Crotoxin, a potent neurotoxin from the venom of the South American rattlesnake Crotalus durissus terrificus, exists as a heterodimer formed between a phospholipase A 2 and a catalytically inactive acidic phospholipase A 2 analogue (crotapotin). Large single crystals of the crotoxin complex and of the isolated subunits have been obtained. The crotoxin complex crystal belongs to the orthorhombic space group P2 1 2 1 2, with unit-cell parameters a = 38.2, b = 68.7, c = 84.2 Å , and diffracted to 1.75 Å resolution. The crystal of the phospholipase A 2 domain belongs to the hexagonal space group P6 1 22 (or its enantiomorph P6 5 22), with unit-cell parameters a = b = 38.7, c = 286.7 Å , and diffracted to 2.6 Å resolution. The crotapotin crystal diffracted to 2.3 Å resolution; however, the highly diffuse diffraction pattern did not permit unambiguous assignment of the unit-cell parameters.
Introduction
Crotoxin, the major protein present in the venom of the Brazilian rattlesnake (Crotalus durissus terrificus), is a very potent myotoxic neurotoxin (Slotta & Fraenkel-Conrat, 1938; Ponce-Soto et al., 2007) that blocks the transmission of neuromuscular signals (Bon et al., 1989; Gopalakrishnakone et al., 1984) . Crotoxin is a heterodimeric complex composed of two distinct subunits: a basic component (component B; MW = 14 350 Da, pI ' 8.2) which possesses phospholipase activity and an acidic nontoxic catalytically inactive protein, crotapotin (component A; MW = 9490 Da, pI ' 3.4) Hendon & Fraenkel-Conrat, 1971; Rubsamen et al., 1971; Dorandeu et al., 2002) . Whilst the isolated subunits are either nontoxic or are only mildly toxic, they recombine to form a complex which exhibits the same toxicity as the original sample (Hendon & Fraenkel-Conrat, 1971; Habermann et al., 1972; Dorandeu et al., 2002) . Crotoxin has received attention owing to its cytotoxic activity against a variety of murine (Corin et al., 1993) and human tumour cell lines in vitro (Rudd et al., 1994) . Antitumour efficacy in vivo, using daily administration of crotoxin, has been demonstrated on Lewis lung carcinoma (83% growth inhibition; Newman et al., 1993) and MX-1 human mammary carcinoma (69% growth inhibition). A lower activity (44% growth inhibition) was observed with HL-60 leukaemia cells, suggesting that crotoxin may possess specificity towards solid tumours (Cura et al., 2002) . Recently, several groups have described other pharmacological activities of crotoxin, such as opiate and acetylcholine-independent analgesic actions (Zhang et al., 2006) , inhibition of the activity of small GTPases in rat macrophages (Sampaio et al., 2006) and immunosuppresive effects (Rangel- .
Crotapotin consists of three polypeptide chains linked together by disulfide bridges and acts as an inhibitory 'chaperone' subunit that prevents promiscuous interactions of the phospholipase with phospholipids on membrane surfaces other than its target membrane. The currently accepted model suggests that when the crotoxin complex reaches the target membrane, the complex dissociates and the enzymatically active phospholipase subunit binds, whilst crotapotin, the inactive subunit, is released in solution (Hawgood & Smith, 1977; Jeng et al., 1978; Bon et al., 1979) . Although crotapotin is enzymati-cally inactive (Habermann & Breithaupt, 1978; Bon et al., 1979; Verheij et al., 1980; Gopalakrishnakone et al., 1984) , it increases the toxicity of phospholipase A 2 by approximately tenfold (Bon, 1982) and also seems to play a role in oligomeric assembly, protein transport, DNA replication and mRNA turnover (Ellis, 1990) . It has been reported that crotapotin has an inhibitory effect on mouse paw oedema, myonecrosis and liposome membrane disruption induced by both catalytically active Asp49 and naturally occurring inactive Lys49 mutant (Arni et al., 1995; Murakami & Arni, 2003) phospholipases A 2 from various snake venoms (Landucci et al., 2000; Cecchini et al., 2004) .
The single-chain phospholipase A 2 subunit (PLA 2 ; EC 3.1.1.4), intramolecularly cross-linked by eight disulfide bridges, catalyses the hydrolysis of the acyl ester bond at the sn-2 position of phospholipids (Baek et al., 2000) based on a catalytic mechanism similar to that of mammalian sPLA 2 s (Gelb et al., 1995) . This PLA 2 subunit induces neurotoxicity (Harris, 1991; Faure et al., 2000) and myotoxicity (Gopalakrishnakone et al., 1984; Kouyoumdjian et al., 1986; Mebs & Ownby, 1990; Rangel-Santos, Dos-Santos et al., 2004) via selective membrane-binding sites that direct it to specific cellular targets (Kini & Evans, 1989 ) and activates specific cytokines (IL-1 and TNF-) which can lead to the release of arachidonic acid and the subsequent production of other pro-inflammatory mediators (prostaglandins, leukotrienes and platelet-activating factors; Crowl et al., 1991; Kudo et al., 1993; Vadas et al., 1993) .
Crystallization and data collection of crotoxin (Achari et al., 1985) and the homologous heterodimeric Mojave toxin from C. viridis viridis (Ownby et al., 1997) have been reported. Although these share high sequence homology with other phospholipases A 2 (>80%) for which structures have been determined, molecular replacement has been unsuccessful in determining the structures of these heterodimeric proteins. Thus, in order to clarify the molecular basis for the pharmacokinetic properties of crotoxin, we have successfully crystallized crotoxin in the absence of amines such as pyridine and collected X-ray diffraction data. We have also crystallized the isolated subunits of the crotoxin complex.
Materials and methods

Purification of the crotoxin complex and its subunits
The crude venom of C. durissus terrificus was obtained from a local serpentarium (Ilha Solteira, Brazil) and the crotoxin complex was isolated by gel filtration using Sephadex G-75 (Amersham Biosciences) followed by anion-exchange chromatography on a Resource Q column (Amersham Biosciences). Crotoxin dissociation and isolation of subunits was performed following the procedure of Hendon & Fraenkel-Conrat (1971) . The purity and homogeneity were checked with SDS--PAGE (purity >98%; Laemmli, 1970) and the protein concentration was measured by the Bradford method (Bradford, 1976) .
Crystallization
The crotoxin complex and both subunits were concentrated using microconcentrators (Centripep, Amicon) to 10 mg ml À1 and stored in 20 mM Tris-HCl buffer pH 8.0. Crystallization trials were carried out by the hanging-drop vapour-diffusion method in 24-well tissueculture plates using Crystal Screen HR2-110 and HR2-112 (Hampton Research). Typically, 1 ml drops of protein solution were mixed with an equal volume of screening solution and equilibrated over a reservoir containing 1 ml of the latter. Once initial crystallization conditions had been determined, they were optimized for the three samples at 291 K. Crystals of the PLA 2 subunit were obtained from a reservoir solution containing 0.1 M Tris-HCl pH 8.5 and 8%(w/v) PEG 8000; they grew to dimensions of 0.6 Â 0.1 Â 0.1 mm within 17 d (Fig. 1a ). Suitable crystals of the crotapotin subunit were obtained from a reservoir solution containing 0.05 M cadmium sulfate, 0.1 M HEPES pH 7.5 and 1 M sodium acetate and grew to dimensions of 0.8 Â 0.2 Â 0.2 mm within 30 d (Fig. 1b ). Crotoxin crystals with maximum dimensions of 0.2 Â 0.2 Â 0.03 mm were obtained from a solution containing 28%(v/v) PEG 400, 0.1 M HEPES pH 7.5, 0.2 M calcium chloride dehydrate and 3-9%(v/v) glycerol.
X-ray data collection and analysis
X-ray diffraction data were collected at the DB03-MX1 beamline at the Laborató rio Nacional de Luz Síncrotron (LNLS, Campinas-Brazil; Polikarpov et al., 1998) . A single crystal was soaked in reservoir solution that additionally contained 20% glycerol and was flash-frozen in a gaseous nitrogen stream at 100 K. The wavelength of the radiation source was set to 1.43 Å and a MAR CCD detector was used to record the X-ray diffraction data for the crotapotin and PLA 2 subunits. For data collection from the crotoxin complex crystals, the wavelength of the radiation source was set to 1.54 Å and a MAR345 image-plate detector was used. The raw intensities were indexed, integrated, reduced and scaled using the DENZO and SCALEPACK programs from the HKL suite (Otwinowski & Minor, 1997) . Photomicrographs of (a) PLA 2 and (b) crotapotin crystals.
Results and discussion
Crotoxin complex
A single crystal with maximum dimensions of 0.2 Â 0.2 Â 0.03 mm was used for X-ray diffraction data collection to 1.75 Å resolution under cryogenic conditions (100 K). The intensities were indexed in the orthorhombic space group P2 1 2 1 2 based on the systematic absences, with unit-cell parameters a = 38.2, b = 68.7, c = 84.2 Å . Processing of the 417 235 measured reflections led to an R merge of 7.0% (57.9% in the last shell, 1.79-1.75 Å resolution) and a completeness of 99.4% (99.6% in the last shell). Taking into consideration the molecular weight of 23 840 Da, one heterodimer is present in the asymmetric unit with a corresponding Matthews coefficient of 2.0 Å 3 Da À1 and a solvent content of 37.2% (Matthews, 1968) . Data-processing statistics are presented in Table 1 .
PLA 2 subunit
Single crystals with dimensions of 0.6 Â 0.1 Â 0.1 mm were used for X-ray diffraction data collection to 2.6 Å resolution under cryogenic conditions (100 K). The intensities were indexed in the hexagonal space group P622, with unit-cell parameters a = b = 38.7, c = 286.7 Å . Examination of the systematic absences indicated that the crystals belonged to either space group P6 1 22 or to its enantiomorph P6 5 22. Processing of the 331 117 measured reflections led to a data set to 2.6 Å resolution with an R merge of 8.8% (14.0% in the last shell, 2.69-2.60 Å resolution) and a completeness of 99.3% (99.1% in the last shell). Assuming a molecular weight of 14 350 Da, the solventcontent calculations (Matthews, 1968) indicate the presence of a single molecule in the asymmetric unit with a corresponding Matthews coefficient of 2.2 Å 3 Da À1 and a solvent content of 42.6%. The crystal parameters and data-processing statistics are summarized in Table 1 .
Crotapotin subunit
Single crystals with dimensions 0.8 Â 0.2 Â 0.2 mm were used for X-ray diffraction experiments and the data were collected to 2.3 Å resolution under cryogenic conditions (100 K). The X-ray diffraction pattern was characterized by diffuse elongated irregular spots. Various algorithms implemented in DENZO (Otwinowski & Minor, 1997) , the XDS package (Kabsch, 1993) , MOSFLM (Leslie, 1992) and LABELIT (Sauter et al., 2004) were used in an attempt to index the reflections. However, no clear solution was obtained.
Concluding remarks
The structures of a large number of phospholipases A 2 have been deposited with the Protein Data Bank and based on the high sequence homology, a number of search models have been generated. However, no clear solution has been obtained by molecular replacement to date for either the heterodimer or the isolated subunits. To overcome this, the 'quick cryo-soaking' technique will be used (Dauter et al., 2000) . 
